86 related articles for article (PubMed ID: 20815792)
1. Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections.
Chono S; Suzuki H; Togami K; Morimoto K
Drug Dev Ind Pharm; 2011 Apr; 37(4):367-72. PubMed ID: 20815792
[TBL] [Abstract][Full Text] [Related]
2. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections.
Chono S; Tanino T; Seki T; Morimoto K
J Control Release; 2008 Apr; 127(1):50-8. PubMed ID: 18230410
[TBL] [Abstract][Full Text] [Related]
3. Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes.
Chono S; Tanino T; Seki T; Morimoto K
J Drug Target; 2006 Sep; 14(8):557-66. PubMed ID: 17043040
[TBL] [Abstract][Full Text] [Related]
4. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.
Moazeni E; Gilani K; Sotoudegan F; Pardakhty A; Najafabadi AR; Ghalandari R; Fazeli MR; Jamalifar H
J Microencapsul; 2010; 27(7):618-27. PubMed ID: 20681747
[TBL] [Abstract][Full Text] [Related]
5. Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects.
Chono S; Tanino T; Seki T; Morimoto K
Drug Dev Ind Pharm; 2008 Oct; 34(10):1090-6. PubMed ID: 18777242
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic efficacy of intrapulmonary administration of ciprofloxacin for the treatment of respiratory infections.
Chono S; Tanino T; Seki T; Morimoto K
Drug Metab Pharmacokinet; 2007 Apr; 22(2):88-95. PubMed ID: 17495415
[TBL] [Abstract][Full Text] [Related]
7. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
[TBL] [Abstract][Full Text] [Related]
8. Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.
Bakker-Woudenberg IA; ten Kate MT; Guo L; Working P; Mouton JW
Antimicrob Agents Chemother; 2001 May; 45(5):1487-92. PubMed ID: 11302815
[TBL] [Abstract][Full Text] [Related]
9. [Designs of optimized microbial therapy systems of respiratory infections].
Morimoto K
Yakugaku Zasshi; 2013; 133(1):81-92. PubMed ID: 23292024
[TBL] [Abstract][Full Text] [Related]
10. [Development of drug delivery systems for targeting to macrophages].
Chono S
Yakugaku Zasshi; 2007 Sep; 127(9):1419-30. PubMed ID: 17827922
[TBL] [Abstract][Full Text] [Related]
11. Local inflammation alters the lung disposition of a drug loaded pegylated liposome after pulmonary dosing to rats.
Haque S; Feeney O; Meeusen E; Boyd BJ; McIntosh MP; Pouton CW; Whittaker M; Kaminskas LM
J Control Release; 2019 Aug; 307():32-43. PubMed ID: 31152749
[TBL] [Abstract][Full Text] [Related]
12. Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluids on alveolar surfaces.
Kaneko K; Togami K; Yamamoto E; Wang S; Morimoto K; Itagaki S; Chono S
Drug Deliv Transl Res; 2016 Oct; 6(5):565-71. PubMed ID: 27334278
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro chondrotoxicity of ciprofloxacin in juvenile rats.
Li P; Cheng NN; Chen BY; Wang YM
Acta Pharmacol Sin; 2004 Oct; 25(10):1262-6. PubMed ID: 15456526
[TBL] [Abstract][Full Text] [Related]
14. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
Sweeney LG; Wang Z; Loebenberg R; Wong JP; Lange CF; Finlay WH
Int J Pharm; 2005 Nov; 305(1-2):180-5. PubMed ID: 16242277
[TBL] [Abstract][Full Text] [Related]
15. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381
[TBL] [Abstract][Full Text] [Related]
16. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
[TBL] [Abstract][Full Text] [Related]
17. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the clinical efficacy and dosage of intravenous ciprofloxacin in patients with respiratory infection.
Matsuo K; Azuma M; Kasai M; Hanji I; Kimura I; Kosugi T; Suga N; Satoh M
J Pharm Pharm Sci; 2009 Jan; 11(2):111s-117s. PubMed ID: 19203473
[TBL] [Abstract][Full Text] [Related]
19. Triggered release of ciprofloxacin from nanostructured agglomerated vesicles.
Bhavane R; Karathanasis E; Annapragada AV
Int J Nanomedicine; 2007; 2(3):407-18. PubMed ID: 18019839
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics and clinical efficacy of ciprofloxacin in aged patients with chronic respiratory diseases].
Teramoto S; Fukuchi Y; Nagase T; Orimo H
Jpn J Antibiot; 1992 May; 45(5):507-11. PubMed ID: 1512936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
